We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOGO
3076
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$179K ﹤0.01%
+15,500
New +$190K
UBNK
3077
DELISTED
United Financial Bancorp, Inc.
UBNK
$178K ﹤0.01%
10,074
BAC.WS.A
3078
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$178K ﹤0.01%
10,142
+30
+0.3% +$465
KTOS icon
3079
Kratos Defense & Security Solutions
KTOS
$11.4B
$177K ﹤0.01%
16,722
-4,807
-22% -$54.8K
NUW icon
3080
Nuveen AMT-Free Municipal Value Fund
NUW
$252M
$177K ﹤0.01%
10,246
+46
+0.5% +$800
AXU
3081
DELISTED
Alexco Resource Corp
AXU
$177K ﹤0.01%
111,152
-1,047
-0.9% -$1.42K
MYN icon
3082
BlackRock MuniYield New York Quality Fund
MYN
$377M
$176K ﹤0.01%
13,604
+382
+3% +$4.98K
KDNY
3083
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$176K ﹤0.01%
4,699
+9
+0.2% +$393
AVP
3084
DELISTED
Avon Products, Inc.
AVP
$175K ﹤0.01%
81,210
-30,800
-27% -$66.2K
VSTM icon
3085
Verastem
VSTM
$610M
$173K ﹤0.01%
4,691
-176
-4% -$7.95K
ADVM
3086
DELISTED
Adverum Biotechnologies
ADVM
$172K ﹤0.01%
+4,900
New +$161K
NIM icon
3087
Nuveen Select Maturities Municipal Fund
NIM
$117M
$172K ﹤0.01%
17,250
CDZI icon
3088
Cadiz
CDZI
$291M
$171K ﹤0.01%
+12,000
New +$158K
PMT
3089
PennyMac Mortgage Investment
PMT
$842M
$171K ﹤0.01%
10,669
-1,648
-13% -$26.7K
AIF
3090
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$171K ﹤0.01%
+10,850
New +$173K
CDTX
3091
DELISTED
Cidara Therapeutics
CDTX
$170K ﹤0.01%
1,249
-311
-20% -$47.2K
MCI
3092
Barings Corporate Investors
MCI
$345M
$170K ﹤0.01%
+11,118
New +$175K
SSRM icon
3093
SSR Mining
SSRM
$6.48B
$170K ﹤0.01%
19,336
+6,045
+45% +$55.7K
MUH
3094
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
$170K ﹤0.01%
11,475
+131
+1% +$1.97K
NSH
3095
DELISTED
NuStar GP Holdings LLC
NSH
$168K ﹤0.01%
+10,710
New +$178K
NE
3096
DELISTED
Noble Corporation
NE
$167K ﹤0.01%
36,899
-291,310
-89% -$1.21M
FUND
3097
Sprott Focus Trust
FUND
$308M
$165K ﹤0.01%
20,848
+42
+0.2% +$329
UWN
3098
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
$164K ﹤0.01%
61,300
-2,000
-3% -$4.75K
MFM
3099
Aberdeen Municipal Income Fund
MFM
$224M
$163K ﹤0.01%
23,710
+3,068
+15% +$21.4K
MIXT
3100
DELISTED
MIX TELEMATICS LIMITED
MIXT
$162K ﹤0.01%
12,682

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.